Trends in mortality rates from malignant melanoma in Sweden 1953-1987 and forecasts up to 2007.

por Thörn, M., Sparén, P., Bergström, R., Adami, H. O.
Publicado 1992

Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden.

por Wassberg, C., Thörn, M., Yuen, J., Ringborg, U., Hakulinen, T.
Publicado 1996

Trends in breast cancer incidence in Sweden 1958-1988 by time period and birth cohort.

por Persson, I., Bergström, R., Sparén, P., Thörn, M., Adami, H. O.
Publicado 1993

Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden.

por Thörn, M., Pontén, F., Bergström, R., Sparén, P., Adami, H. O.
Publicado 1994

Sentinel node lymphocytes: tumour reactive lymphocytes identified intraoperatively for the use in immunotherapy of colon cancer

por Marits, P, Karlsson, M, Dahl, K, Larsson, P, Wanders, A, Thörn, M, Winqvist, O
Publicado 2006

P18-02. Peptide pulsed dendritic cells allows for induction of polyfunctional CD4+ T cell responses and help CD8+ T cell targeting subdominant CTL epitopes

por Fomsgaard, A, Karlsson, I, Kløverpris, H, Bonde, J, Thorn, M, Pedersen, AE, Vinner, L, Gram, G, Svane, IM, Gerstoft, J, Kronborg, G
Publicado 2009